These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11895455)

  • 1. Sodium-lithium countertransport is increased in normoalbuminuric type 1 diabetes but is not related to other risk factors for microangiopathy.
    Vervoort G; Elving LD; Wetzels JF; Lutterman JA; Smits P; de Pont JJ; Berden JH
    Eur J Clin Invest; 2002 Feb; 32(2):93-9. PubMed ID: 11895455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
    Chiarelli F; Catino M; Tumini S; de Martino M; Mezzetti A; Verrotti A; Vanelli M
    Diabetes Care; 1999 Jul; 22(7):1158-64. PubMed ID: 10388982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na/Li countertransport abnormalities in type 1 diabetes with and without nephropathy are familial.
    Mead PA; Wilkinson R; Thomas TH
    Diabetes Care; 2001 Mar; 24(3):527-32. PubMed ID: 11289480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM.
    Monciotti CG; Semplicini A; Morocutti A; Maioli M; Cipollina MR; Barzon I; Palaro C; Brocco E; Trevisan M; Fioretto P; Crepaldi G; Nosadini R
    Diabetologia; 1997 Jun; 40(6):654-61. PubMed ID: 9222644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in erythrocyte sodium-lithium countertransport kinetics in diabetic nephropathy.
    Rutherford PA; Thomas TH; Carr SJ; Taylor R; Wilkinson R
    Clin Sci (Lond); 1992 Mar; 82(3):301-7. PubMed ID: 1312415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium-lithium transport in adolescents with IDDM. Relationship to incipient nephropathy and glycemic control.
    Crompton CH; Balfe JW; Balfe JA; Chatzilias A; Daneman D
    Diabetes Care; 1994 Jul; 17(7):704-10. PubMed ID: 7924781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiol group modulation of sodium-lithium countertransport kinetics in diabetic nephropathy.
    Jones SC; Thomas TH; Marshall SM
    Diabetologia; 1997 Sep; 40(9):1079-84. PubMed ID: 9300245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic predisposition to hypertension (as detected by Na+/Li+ countertransport) and risk of diabetic nephropathy in childhood diabetes.
    Chiarelli F; Verrotti A; Kalter-Leibovici O; Laron Z; Morgese G
    J Paediatr Child Health; 1994 Dec; 30(6):547-9. PubMed ID: 7865273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal kinetics of erythrocyte sodium lithium countertransport in patients with diabetic nephropathy in Thailand.
    Vareesangthip K; Panthongdee W; Shayakul C; Nitiyanant W; Ong-Aj-Yooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S48-53. PubMed ID: 17044454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte sodium-lithium countertransport activity and total body insulin-mediated glucose disposal in normoalbuminuric normotensive type 1 (insulin-dependent) diabetic patients.
    Catalano C; Winocour PH; Thomas TH; Walker M; Sum CF; Wilkinson R; Alberti KG
    Diabetologia; 1993 Jan; 36(1):52-6. PubMed ID: 8436253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcapillary escape rate of albumin is increased and related to haemodynamic changes in normo-albuminuric type 1 diabetic patients.
    Vervoort G; Lutterman JA; Smits P; Berden JH; Wetzels JF
    J Hypertens; 1999 Dec; 17(12 Pt 2):1911-6. PubMed ID: 10703889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated erythrocyte sodium-lithium counter-transport in hypertensive patients with non-insulin-dependent diabetes mellitus.
    Senda T; Serizawa N; Negishi K; Katayama S
    Diabetes Res Clin Pract; 1996 Mar; 31(1-3):37-44. PubMed ID: 8792100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium activation kinetics of red blood cell Na+/Li+ countertransport in diabetes: methodology and controversy.
    Canessa M; Zerbini G; Laffel LM
    J Am Soc Nephrol; 1992 Oct; 3(4 Suppl):S41-9. PubMed ID: 1457760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Na+/Li+ and Na+/H+ countertransport activity in hypertensive non-insulin-dependent diabetic patients: role of insulin resistance and antihypertensive treatment.
    Giordano M; Castellino P; Solini A; Canessa ML; DeFronzo RA
    Metabolism; 1997 Nov; 46(11):1316-23. PubMed ID: 9361692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcapillary escape rate of albumin in type II diabetic patients. The relationship with microalbuminuria and hypertension.
    Nannipieri M; Penno G; Rizzo L; Pucci L; Bandinelli S; Mattei P; Taddei S; Salvetti A; Navalesi R
    Diabetes Care; 1997 Jun; 20(6):1019-26. PubMed ID: 9167118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic behavior of the erythrocyte sodium-lithium countertransporter in nonnephropathic diabetic twins.
    Hardman TC; Dubrey SW; Leslie RD; Lant AF
    Metabolism; 1996 Oct; 45(10):1203-7. PubMed ID: 8843173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte sodium-lithium countertransport activity in non-nephropathic diabetic twins.
    Hardman TC; Dubrey SW; Leslie RD; Lant AF
    Diabetes Care; 1996 Jan; 19(1):32-8. PubMed ID: 8720530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte sodium-lithium countertransport, adenosine triphosphatase activity and sodium-potassium fluxes in insulin-dependent diabetes.
    Besch W; Blücher H; Bettin D; Wolf E; Michaelis D; Kohnert KD
    Int J Clin Lab Res; 1995; 25(2):104-9. PubMed ID: 7663004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erythrocyte sodium-lithium countertransport in diabetic children: 12 months development and relationship with familial hypertension].
    Guarena C; Boero R; Quarello F; Cerruti F; Rolando B; Sacchetti C; Rosati C; Iadarola G; Piccoli G
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1205-7. PubMed ID: 1482260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucocyte Na+/H+ antiport activity in type 1 (insulin-dependent) diabetic patients with nephropathy.
    Ng LL; Simmons D; Frighi V; Garrido MC; Bomford J; Hockaday TD
    Diabetologia; 1990 Jun; 33(6):371-7. PubMed ID: 2165946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.